Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
- Y. Tanaka
- , T. Takeuchi
- , T. Mimori
- , K. Saito
- , M. Nawata
- , H. Kameda
- , T. Nojima
- , N. Miyasaka
- , T. Koike
Research output: Contribution to journal › Article › peer-review
246
Link opens in a new tab
Citations
(Scopus)